Guidance

PVL-Staphylococcus aureus infections: diagnosis and management

Advice on the recognition, investigation and management of Panton-Valentine Leukocidin (PVL)-Staphylococcus aureus (PVL-SA) cases.

• From: UK Health Security Agency
• Published: 2 November 2008

Documents

Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England

PDF, 1.56 MB, 51 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This content was originally produced by the Health Protection Agency (HPA). This content is now owned and managed by the UK Health Security Agency (UKHSA).

This guidance was prepared by a sub-group of the Steering Group on Healthcare Associated Infections at the request of the Department of Health and replaces the draft produced by Health Protection Agency working group in 2006. It provides healthcare professionals with easily accessible advice on the recognition, investigation and management of PVL-Staphylococcus aureus cases.

Published 2 November 2008